Publication | Closed Access

Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial

Diabetes ManagementDiabetesPharmacologyClinical TrialsType 2PharmacotherapySurpass J-comboDiabetes MellitusMedicine